An efficient method to obtain 4-alkoxy-2-oxo-but-3-enoic acid ethyl esters 
Introduction
The synthesis of pyrazole and its analogues has been a subject of consistent interest because of the wide range of applications for such heterocycles in the pharmaceutical and agrochemical industries.
1 Therefore, extensive research efforts are continually directed at the discovery of new heterocycles with appropriate pharmacological effects. Among their range of properties, the compounds containing a pyrazole scaffold have been shown to exhibit HIV-1 reverse transcriptase and IL-1 synthesis inhibition, as well as antihyperglycemic, antibacterial, sedativehypnotic, anti-inflammatory, antipyretic and analgesic activity. 2 In part, the anti-inflammatory, 3-alken-2-ones have been found to be powerful precursors for the synthesis of carboxyl derivative heterocycles, as the trichloromethyl group undergoes a hydrolysis reaction when treated with either alcohols, sulfuric acid (96%) or their mixture in water. 8 However, the use of unsymmetrically substituted precursors often leads to a mixture of regioisomers hindering the use of this method for regiospecifically obtaining the carboxyalkylpyrazole derivatives by a onepot procedure. 9 Thus, we became interested in a 1,3-dielectrophilic precursor, already substituted with a carboxyalkyl group, aiming toward a more general, efficient and regiospecific synthesis of such heterocyclic compounds. With regards to the synthesis of carboxylpyrazoles, other methods and precursors have been found in the literature, 10 however, they have been reported to present disadvantages, mainly due to their limited scopes and the use of substrates not readily available. We thus decided that the reported acylation 11a of enol ethers with ethyl oxalyl chloride deserved reinvestigation as a general method to synthesize 4-alkoxy-2-oxo-3-butenoic esters (1,3-dielectrophilic compounds), because of the simplicity of the procedure. Another method that has been performed for the synthesis of compounds such as 2a (Scheme 2), consists in the methylation of ethyl 2,4-dioxopentanoate with diazomethane. However, this method showed serious problems, such as a mixture of isomers, low yields and also the limitation of the synthesis of only one compound. 11b Furthermore, an analogous to compound 2b (Scheme 2) has also been reported in the literature, this compound showing an ethoxy instead of a methoxy group at the 4 position of the 4-alkoxy-2-oxo-3-butenoic ester.
11c
In addition, as part of our research program, we were interested in obtaining compounds endowed with anti-inflammatory, antipyretic and mainly analgesic activity. Our contributions in this field include the investigation of novel pyrazole derivatives in animal models of inflammation, fever and pain. 12 In that study, the presence of 5-trihalomethyl-4,5-dihydro-1H-pyrazole 12a-d as well as of a 5-ethoxycarbonyl pyrazole 12e ring were a determining factor in obtaining compounds with good antipyretic and analgesic properties against neurogenic, inflammatory and visceral pain in rodents. Thus, considering the analgesic efficacy of 4,5-dihydro-1H-pyrazoles, we intend to explore the hypothesis that their hybridization with salicylic acid can supply the design of novel potent analgesic agents (Scheme 1). Salicylic acid is known to present numerous therapeutic applications such as: anti-arthritic, antineuralgic, antirheumatic, anti-thrombotic, keratolytic, antiseptic, anti-inflammatory, antipyretic and analgesic activity. 13 Therefore, the hybridization of these two scaffolds, which share analgesic and antipyretic properties, may contribute in a synergistic manner to bring about an evolution of activity in a second-generation of molecules. 
Results and Discussion
The acylation of enol ethers 1a,f with ethyl oxalyl chloride (Scheme 2) in pyridine was carried out with an equal molar ratio using anhydrous chloroform as solvent. The most satisfactory results were obtained when the reactions were performed at between 0°C and room temperature for 16h (2f) or from 0°C to 35°C for 18h (2a) .
In an attempt to expand the scope of the reaction by making use of observations made previously in our laboratory, 14 we also performed the acylation of acetophenone acetals 1b-e with ethyl oxalyl chloride. This activated acyl halide reacted with the enol ethers, generated in situ from the respective acetals, furnishing the 4-Aryl-4-methoxy-2-oxo-3-butenoic esters 2b-e as a one-pot procedure in good yields. This reaction was carried out using acetal, pyridine and the acylating agent at a molar ratio of 1:2:2, in reflux of chloroform for 5 h. The second equivalent of acylant trapped the methoxyl group, liberated from acetal, forming methyl ethyl oxalate, which was separated from the product by distillation. The acetals 1b-e were synthesized from the reaction of the respective ketone with trimethyl orthoformate in the presence of ptoluenesulfonic acid. (ii) CH 3 C(OMe) 2 R1 (1b-e), CHCl 3 , Py, 0° to 65°C, 5 h.
Scheme 2
The 1 H and 13 C NMR spectra of products 2a-f showed sets of signals corresponding to the proposed structures with the vinylic hydrogen (H-3) at a range of δ 6.13-7.59. In a second step, our efforts were focused on the synthesis of new salicylate-containing dihydropyrazoles and on the validation of the method of hybridization used for obtaining compounds endowed with analgesic activity. Although some trifluoromethyl salicylatecontaining dihydropyrazoles have been described in the literature, 16 the presence of this moiety has been justified due to the unique physical and biological properties of fluorine when attached to drug-like compounds. 17a In many systems, the substitution of the methyl group by a trifluoromethyl group, for example, results in added lipophilicity [π (CF3) = 1.07 versus π (CH3) = 0.50], 17b which may lead to easier absorption and transportation of the molecules within biological systems and thereby improve the overall pharmacokinetic properties of the compounds. The synthetic procedure for the preparation of such compounds employed two simple protocols: (i) the reaction of methyl salicylate with hydrazine hydrate to give the corresponding hydrazide and (ii) the cyclocondensation reaction of the hydrazide 4 with appropriate α,β-unsaturated ketones 2,5 (Scheme 3). The salicylic hydrazide 4 was readily available from the reaction of hydrazine hydrate with ester 3 in reflux of anhydrous ethanol for 5 h, in accordance with the previously reported procedure. 19 The crystalline product was isolated in good yield (78%). The second step was carried out from the cyclocondensation of previously synthesized 4- The 4-alkyl(aryl)-1,1,1-trifluoro-3-alken-2-ones 5a-f were synthesized from the reaction of the respective enol ether (1a,f) or acetal (1b-e) with trifluoroacetic anhydride according to previous publications. 20 The reaction of α, β-unsaturated ketones 2,5 with salicylic hydrazide was conducted in the presence of methanol or ethanol at reflux for 16 h. The 4,5-dihydro-1H-pyrazoles 6,7 were obtained regiospecifically with satisfactory yields (60-96%). As can be verified from extensive reports from our laboratories, 7a the 4,5-dihydro-1H-pyrazoles were highly stable and could be isolated. In most cases, these compounds were obtained when the N-1 or C-5 was substituted by a strong electron-withdrawing group that hindered the elimination of water and a subsequent aromatization of the pyrazole ring. 1a,7a In the present study, we synthesized compounds that possessed in their structures a combination of effects that avoided the dehydration reaction: a 2-hydroxybenzoyl group attached on N-1 and an ethyl carboxylate or trifluoromethyl group on C-5. Pyrazoles 6,7 showed sets of 1 H and 13 C NMR data that corresponded to the proposed 1 H and 13 C NMR data of compounds 6f and 7f showed that only one pair of the diastereoisomers was obtained. Semi-empirical AM1 calculations 21 showed that the diastereoisomer pair 5S4R/5R4S were 1.95 kcal.mol -1 (6f) and 1.52 kcal.mol -1 (7f) more stable than the diastereoisomer pair 5S4S/5R4R. These data are supported by previously reported crystallographic studies from analogous compounds. 22 The difference in energy between the two 6e 7e
pairs of diastereoisomers suggests that the formation (> 93%) of compounds 6f and 7f supply the hydroxyl and methyl group situated cis to one another. The structures of compounds 6e and 7e were also supported by crystal X-ray diffraction (Figure 2 ). These crystallographic studies confirmed the existence of hydrogen bonds involving the 2-hydroxybenzoyl moiety that was suggested from the downfield peak (broad) of the phenol proton (around 10. Tables 1 and 2 . 23 In an attempt to validate our hybridization method, the analgesic activity of compounds 6a and 7a was evaluated by the acetic acid writhing test in mice as previously described. 24 In this classic test, the intraperitoneal administration of 0.8% of acetic acid (10 mL/Kg) causes a writhing (stretching) behavior in the animal which is interpreted as its pain response. The number of writhing responses was then counted over a period of 10 min. In addition, the locomotor activity of the animals was evaluated on a rotarod apparatus. The compounds tested did not alter rotarod performance (data not shown) suggesting that they did not induce any form of gross motor impairment.
Oral administration of compounds 6a and 7a (500 µmol/Kg) caused a significant analgesic effect in the writhing test (Figure 3 ). This effect was similar to that obtained with the analgesic activity presented by aspirin, a classical salicylate derivative in clinical use, as no significant difference between aspirin and compounds 6a and 7a was observed. Among the 4,5-dihydro-1H-pyrazoles tested, the first insight obtained was that compound 7a presented better efficacy than 6a. In summary, a simple and efficient method for the synthesis of 4-alkoxy-2-oxo-3-butenoic esters was reported. Regiospecific cyclocondensation of these substrates and their trifluoromethylated analogues with salicylic hydrazide led to the 4,5-dihydro-1H-pyrazole derivatives in good yields. In addition, the structures of these series of compounds were also supported by crystallographic studies. The hybridized compounds 6a and 7a showed interesting analgesic activity in mice, validating this design for the construction of novel analgesic agents. Further investigations are in progress to elucidate the structural requirements for the analgesic effect of this class of compounds, as well as their action on other models of pain. Finally, our preliminary findings showed the synthesized 4,5-dihydro-1H-pyrazole derivatives as promising prototypes for the treatment of states of pain.
Experimental Section
General Procedures. Unless otherwise indicated, all common reagents were used as obtained from commercial suppliers without further purification. The solvents were dried and purified according to recommended procedures. 25 All melting points were measured using a Reichert- packages. The CHN elemental analyses were performed on a Perkin-Elmer 2400 CHN elemental analyzer (Federal University of Rio Grande do Sul, UFRGS/ Brazil). Statistical treatments of analgesic data were carried out by one-way ANOVA followed by Student-Newman-Keuls test.
General procedure for synthesis of 4-alkoxy-2-oxo-but(pent)-3-enoic acid ethyl esters 2a,f
To a stirred solution of ethyl oxalyl chloride (2.34 ml, 21 mmol) in dry CHCl 3 (20 mL) at 0°C, a solution of enol ether 1 (20 mmol), CHCl 3 (15 mL) and pyridine (1.7 ml, 21 mmol) was added dropwise. The mixture was left to cool for at least 2 h and then was allowed to gradually warm to room temperature and then stirred for 16h to afford the compounds 2f. The acylation of metoxypropene (1b) required heating at 35°C for 18 h. After this time, the mixture was washed with a solution of H 2 O: HCl (10:1) (2 × 10 mL), and with distilled water (2 × 10 mL). The crude products (2a,f) were obtained with satisfactory purity and were used without additional purification.
General procedure for synthesis of (E)-4-aryl-4-methoxy-2-oxo-but-3-enoic acid ethyl esters 2b-e
To a stirred solution of ethyl oxalyl chloride (4.6 ml, 41 mmol) in dry CHCl 3 (25 mL) at 0°C, a solution containing the acetal 1 (20 mmol), CHCl 3 (15 mL) and pyridine (3.25 ml, 41 mmol) was added dropwise. The mixture was left to cool for at least 1 h, then was allowed to warm to room temperature and refluxed for 5h. The remaining workup was done as already described for compounds 2a,f. After the solvent had evaporated the residue was distilled under vacuum to afford product 2. The methyl ethyl oxalylate formed during the course of the reaction was distilled at 50 °C (6.2 mbar). 
